Last updated on January 2014

Study in overweight and obese subjects with CV disease and/or multiple CV risk factors


Brief description of study

Study in overweight and obese subjects with CV disease and/or multiple CV risk factors

Detailed Study Description

A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors

Clinical Study Identifier: TX137663

Contact Investigators or Research Sites near you

Start Over

Lauraine Crandall

Cardiology Research Associates
Daytona Beach, FL USA
  Connect »